This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Topas Therapeutics Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Reinaldo Digigow: Innovator in Nanoparticle Technology
Introduction
Reinaldo Digigow is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of nanoparticle technology, particularly in the development of innovative solutions for medical applications. His work focuses on creating nanoparticles that can induce tolerance to various therapeutic compounds and allergens.
Latest Patents
Reinaldo Digigow holds a patent for "Nanoparticles comprising peptides including an n-terminal linker." This invention provides nanoparticles that can be used in compositions for inducing tolerance to therapeutic compounds, allergens, and autoantigens. The patent also covers the use of these nanoparticles in treating allergies, autoimmune diseases, and food intolerances.
Career Highlights
Reinaldo is associated with Topas Therapeutics GmbH, where he applies his expertise in nanoparticle technology. His innovative approach has positioned him as a key player in the development of therapies that address complex medical challenges.
Collaborations
Reinaldo collaborates with notable colleagues such as Johannes Pohlner and Barbara Metzler. Their combined efforts contribute to advancing research and development in the field of nanoparticle applications.
Conclusion
Reinaldo Digigow's work in nanoparticle technology exemplifies the potential of innovative solutions in medicine. His contributions are paving the way for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile